Response to ‘Diagnosis of aldosterone producing adenomas’  by Chung, S.-D. et al.
dexamethasone suppression.4 Therefore, although Chung
et al. used the dexamethasone-suppression adrenocortical
scintigraphy to show the functional activity of the lesions, the
diagnosis based only on the scintigraphy could lead to
misdiagnosis.5
The CT image Chung et al. presented showed different
contrast enhancement effect in the adrenal lesions, which
indicates that the lesions would have different nature.
Considering that the existence of adrenal nodular lesions in
the patients with hypertension is reported to be not rare,6,7 it
is possible that the only one lesion had aldosterone hyper-
secretion. Because the small size and the NP-59 accumulation
in the case presented by Chung et al. indicate the benign
nature of the lesions,6–8 the resection of the only one lesion
with aldosterone hypersecretion might have been sufficient.
Adrenal vein sampling is now considered to be the most
reliable diagnostic test to detect the site of aldosterone
hypersecretion.9,10 Therefore, we would like to recommend
adrenal vein sampling in the cases under the suspicion of
primary aldosteronism, such as the case presented by Chung
et al. The lesions should better be resected after the
confirmation of their functional activity.
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We certainly appreciated the comments by Dr Tanemoto
et al.1 regarding our report of Diagnosis of bilateral
aldosterone-producing adenomas.2
The preoperative diagnosis of bilateral aldosterone-
producing adenomas remains elusive and can only be
definitely made postoperatively by pathological existence
of typical adenomas in the excised specimen, and strong
expression of the aldosterone synthase by real-time PCR of
the excised tumor.3
Although computed tomography (CT) scanning might
not reliably discriminate bilateral adrenal hyperplasia
(BAH) from aldosterone-producing adenoma (APA),4 pre-
vious reports showed that the finding of a single-focal
macroadenoma on CT scan had a high positive predictive
value when the tumor size was 41.0 cm;5,6 and it will be
more diagnostic of APA when combined with a positive
NP-59 adrenocortical scintigraphy as a valid evaluation tool
for primary aldosteronism.7 Even adrenal vein sampling
(AVS), the gold standard of differential diagnosis of the
subtypes of primary aldosteronism, has its limitation
because of bilateral functional adenomas that may be
present at the same time or metachronously. In our institute,
there were four cases of simultaneous bilateral aldosterone-
producing adenomas among 164 APA patients surgically
treated and which were pathologically documented as APAs.
These four bilateral aldosterone-producing adenoma
patients presented with evidence of bilateral localized up-
takes of NP-59 at dexamethasone-suppressed adrenocortical
scintigraphy, with CT scan demonstrating tumors larger
than 1.0 cm in diameter (1.2–2.0 cm, mean 1.5 cm) and
negative postural test before operation. There were another
three cases of metachronous bilateral aldosterone-producing
adenomas, with the second contralateral tumor clinically
detectable 18–48 months after the first adrenalectomy.8
For this specific patient presented in our report, we also
performed real-time PCR of the aldosterone synthase.2 The
mRNA level of aldosterone synthase (CYP11B2) were
corrected with the mRNA level of glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), and were quantified using real-
time PCR as previously reported,3 and it is expressed as
2DDCT, where DDCT¼ (DCT CYP11B2DCT GAPDH). The
mRNA level of the bilateral tumorous portions and the
nontumorous portions were DDCT, 2.73±0.13 versus 12.47±
0.68 in this patient, indicating much higher mRNA activity in
bilateral tumors, and proved that they both are functional
APAs. And a radiologist was asked to review the CT scans
of that patient again which revealed that his bilateral tumors
were larger than 1.0 cm, and both were enhanced with
contrast medium.
In conclusion, we believed that it is reasonable to
perform bilateral subtotal adrenalectomies in treating
bilateral APAs, which present with aldosterone–renin ratio
4100 ng per 100 ml per ng ml1 h1, plasma aldosterone
420 ng per 100 ml, and bilateral macronodular tumors
(41.0 cm) and positive uptake in the adrenal scan.
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Studying channel and receptor
physiology in podocytes
Kidney International (2008) 73, 364; doi:10.1038/sj.ki.5002669
To the Editor: We would like to congratulate Shankland
et al.1 for their very apt and extensive review regarding the
culturing of podocytes in which they have diligently put forth
the evolution of this technique. Research in the area of renal
glomerular physiology has already seen many technical
developments over the past 100 years, and the latter are still
evolving. This is mainly due to the complicated and
multicellular structure of renal glomeruli and the manner
in which their different cells are naturally arranged and
interact. In fact, the complexity of glomerular architecture
has hindered the progress of detailed and sophisticated
research in this area. Cell culturing methods have been a vital
ingredient for these advances in renal glomerular research.
Podocytes, in culture, present a unique system to study the
biology of these cells but, as was acknowledged by Shankland
et al.,1 this is not the final frontier. With every advance in
research, there is always the need for yet a newer and better
model that more closely approximates the actual native
subject of interest. Past studies have shown that cultured
preparations do not always accurately capture all the features
of the in vivo conditions. For example, cultured cells have
been widely reported to express smooth muscle a-actin,
whereas this protein is not found in vivo as shown by Egler
et al.2 For this reason, it is highly speculative to extrapolate
the results obtained in cultured podocytes (which are highly
constrained within their cell cycle) to their native in vivo
counterparts (which are highly differentiating cells).3 It is far
more preferable to work with intact native structures rather
than with cultured cells, in order to minimize this
confounding factor. With this in mind, we have been
optimizing a system to look at the different glomerular cells,
including podocytes and mesangial cells, in an intact and
native environment in real-time using confocal microscopy.4
In particular, we use 100 mm thin renal cortical slices from
mice, rats and humans. After loading these with the Ca2þ
fluorescent dye fluo-4, changes in fluorescence representing
changes in intracellular Ca2þ concentrations, brought about
by administration of different agonists such as angiotensin II
and endothelin-1, can be captured and recorded. Further
studies are underway using specific cell markers to distin-
guish between different glomerular cell types.
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Diagnosing Alport syndrome
using electron microscopy of the
skin
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To the Editor: Patey-Mariaud de Serre et al.1 reported that
comparing a5(IV) with a2(IV) expression in skin biopsies is
useful in diagnosing X-linked Alport syndrome (AS).
However, a5(IV) staining variation can confuse the diagnosis
and requires a different analytical approach. Morphological
changes in the skin basement membrane determined using
electron microscopy (EM) might provide additional infor-
mation with which to diagnose AS. We found such changes
using EM in a male patient with end-stage renal failure and
AS. His mother had been diagnosed with chronic kidney
disease and had died at the age of 58 years of malignant
lymphoma. Hematoproteinuria had persisted in our patient
since childhood, but a renal biopsy had not been performed.
He had sensorineural hearing loss, but no ocular changes.
We suspected X-linked AS and performed a skin biopsy.
Standard immunofluorescence staining showed normal
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